Precision medicine identifies key recurring mutation in head and neck cancers

(University of California - San Diego) Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.
Source: EurekAlert! - Biology - Category: Biology Source Type: news